KNSA - Kiniksa Pharmaceuticals Ltd - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KNSA is currently covered by 4 analysts with an average price target of $51.04. This is a potential upside of $12.11 (31.11%) from yesterday's end of day stock price of $38.93.

Kiniksa Pharmaceuticals Ltd's activity chart (see below) currently has 67 price targets and 45 ratings on display. The stock rating distribution of KNSA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 85.97% with an average time for these price targets to be met of 1007.8 days.

Highest price target for KNSA is $50, Lowest price target is $35, average price target is $42.25.

Most recent stock forecast was given by GEOFF MEACHAM from CITI on 16-Oct-2025. First documented stock forecast 17-Jun-2018.

Best performing analysts who are covering KNSA - Kiniksa Pharmaceuticals Ltd:

Geoff Meacham Paul Choi Liisa Bayko David Nierengarten Anupam Rama

Currently out of the existing stock ratings of KNSA, 6 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$50

$11.07 (28.44%)

$40

10 days ago
(16-Oct-2025)

5/7 (71.43%)

$11.36 (29.40%)

947

Buy

$44

$5.07 (13.02%)

$34

14 days ago
(12-Oct-2025)

10/11 (90.91%)

$6.97 (18.82%)

957

Buy

$40

$1.07 (2.75%)

$39

11 months 22 days ago
(04-Nov-2024)

8/10 (80%)

$17.97 (81.57%)

736

Buy

$35

$-3.93 (-10.10%)

$30

11 months 28 days ago
(28-Oct-2024)

7/8 (87.5%)

$11.73 (50.41%)

1176

Buy

$32

$-6.93 (-17.80%)

$24

2 years 3 months 2 days ago
(24-Jul-2023)

8/8 (100%)

$12.52 (64.27%)

1223

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KNSA (Kiniksa Pharmaceuticals Ltd) average time for price targets to be met?

On average it took 1007.8 days on average for the stock forecasts to be realized with a an average price target met ratio 85.97

Which analyst has the current highest performing score on KNSA (Kiniksa Pharmaceuticals Ltd) with a proven track record?

GEOFF MEACHAM

Which analyst has the current lower performing score on KNSA (Kiniksa Pharmaceuticals Ltd) with a proven track record?

ANUPAM RAMA

Which analyst has the most public recommendations on KNSA (Kiniksa Pharmaceuticals Ltd)?

Geoff Meacham works at CITI and has 16 price targets and 11 ratings on KNSA

Which analyst is the currently most bullish on KNSA (Kiniksa Pharmaceuticals Ltd)?

Geoff Meacham with highest potential upside - $11.07

Which analyst is the currently most reserved on KNSA (Kiniksa Pharmaceuticals Ltd)?

Paul Choi with lowest potential downside - -$6.93

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?